{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:58:57Z","timestamp":1790135937634,"version":"4.0.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["K23AG063899"],"award-info":[{"award-number":["K23AG063899"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11910-025-01404-y","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:52:37Z","timestamp":1739001157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Bidirectional Relationship Between Epilepsy and Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"25","author":[{"given":"David","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,8]]},"reference":[{"issue":"3","key":"1404_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s004060050027","volume":"248","author":"HJ M\u00f6ller","year":"1998","unstructured":"M\u00f6ller HJ, Graeber MB. The case described by alois alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections. Eur Arch Psychiatry Clin Neurosci. 1998;248(3):111\u201322. https:\/\/doi.org\/10.1007\/s004060050027.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"1404_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/ageing\/afaa194","volume":"50","author":"LJ Blank","year":"2021","unstructured":"Blank LJ, Acton EK, Thibault D, Willis AW. Neurodegenerative disease is associated with increased incidence of epilepsy: a population based study of older adults. Age Ageing. 2021;50(1):205\u201312. https:\/\/doi.org\/10.1093\/ageing\/afaa194.","journal-title":"Age Ageing"},{"issue":"24","key":"1404_CR3","doi-asserted-by":"publisher","first-page":"e3241","DOI":"10.1212\/WNL.0000000000011077","volume":"95","author":"M Stefanidou","year":"2020","unstructured":"Stefanidou M, Beiser AS, Himali JJ, et al. Bi-directional association between epilepsy and dementia: the framingham heart study. Neurology. 2020;95(24):e3241\u20137. https:\/\/doi.org\/10.1212\/WNL.0000000000011077.","journal-title":"Neurology"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"109640","DOI":"10.1016\/j.yebeh.2024.109640","volume":"152","author":"L Chen","year":"2024","unstructured":"Chen L, Yang W, Yang F, et al. The crosstalk between epilepsy and dementia: a systematic review and meta-analysis. Epilepsy Behav. 2024;152:109640. https:\/\/doi.org\/10.1016\/j.yebeh.2024.109640.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"1404_CR5","doi-asserted-by":"publisher","first-page":"fcac210","DOI":"10.1093\/braincomms\/fcac210","volume":"4","author":"RK Banote","year":"2022","unstructured":"Banote RK, H\u00e5kansson S, Zetterberg H, Zelano J. CSF biomarkers in patients with epilepsy in alzheimer\u2019s disease: a nation-wide study. Brain Commun. 2022;4(4):fcac210. https:\/\/doi.org\/10.1093\/braincomms\/fcac210.","journal-title":"Brain Commun"},{"issue":"10","key":"1404_CR6","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s43587-021-00122-7","volume":"1","author":"A Taubes","year":"2021","unstructured":"Taubes A, Nova P, Zalocusky KA, et al. Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related alzheimer\u2019s disease. Nat Aging. 2021;1(10):932\u201347. https:\/\/doi.org\/10.1038\/s43587-021-00122-7.","journal-title":"Nat Aging"},{"issue":"10","key":"1404_CR7","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s00415-020-09937-7","volume":"267","author":"J V\u00f6glein","year":"2020","unstructured":"V\u00f6glein J, Ricard I, Noachtar S, et al. Seizures in alzheimer\u2019s disease are highly recurrent and associated with a poor disease course. J Neurol. 2020;267(10):2941\u20138. https:\/\/doi.org\/10.1007\/s00415-020-09937-7.","journal-title":"J Neurol"},{"issue":"1","key":"1404_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ene.15089","volume":"29","author":"J V\u00f6glein","year":"2022","unstructured":"V\u00f6glein J, Kostova I, Arzberger T, et al. Seizure prevalence in neurodegenerative diseases-a study of autopsy proven cases. Eur J Neurol. 2022;29(1):12\u20138. https:\/\/doi.org\/10.1111\/ene.15089.","journal-title":"Eur J Neurol"},{"issue":"3","key":"1404_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3233\/JAD-191315","volume":"74","author":"D Arnaldi","year":"2020","unstructured":"Arnaldi D, Donniaquio A, Mattioli P, et al. Epilepsy in neurodegenerative dementias: a clinical, epidemiological, and EEG study. J Alzheimers Dis. 2020;74(3):865\u201374. https:\/\/doi.org\/10.3233\/JAD-191315.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1404_CR10","doi-asserted-by":"publisher","first-page":"e209820","DOI":"10.1212\/WNL.0000000000209820","volume":"103","author":"I Zawar","year":"2024","unstructured":"Zawar I, Kapur J, Mattos MK, Aldridge CM, Manning C, Quigg M. Association of seizure control with cognition in people with normal cognition and mild cognitive impairment. Neurology. 2024;103(6):e209820. https:\/\/doi.org\/10.1212\/WNL.0000000000209820.","journal-title":"Neurology"},{"issue":"12","key":"1404_CR11","doi-asserted-by":"publisher","first-page":"e1686","DOI":"10.1212\/WNL.0000000000010358","volume":"95","author":"C Schnier","year":"2020","unstructured":"Schnier C, Duncan S, Wilkinson T, Mbizvo GK, Chin RFM. A nationwide, retrospective, data-linkage, cohort study of epilepsy and incident dementia. Neurology. 2020;95(12):e1686\u201393. https:\/\/doi.org\/10.1212\/WNL.0000000000010358.","journal-title":"Neurology"},{"issue":"24","key":"1404_CR12","doi-asserted-by":"publisher","first-page":"e3248","DOI":"10.1212\/WNL.0000000000011080","volume":"95","author":"EL Johnson","year":"2020","unstructured":"Johnson EL, Krauss GL, Kucharska-Newton A, et al. Dementia in late-onset epilepsy: the atherosclerosis risk in communities study. Neurology. 2020;95(24):e3248\u201356. https:\/\/doi.org\/10.1212\/WNL.0000000000011080.","journal-title":"Neurology"},{"issue":"6","key":"1404_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/jamaneurol.2020.0187","volume":"77","author":"O Keret","year":"2020","unstructured":"Keret O, Hoang TD, Xia F, Rosen HJ, Yaffe K. Association of late-onset unprovoked seizures of unknown etiology with the risk of developing dementia in older veterans. JAMA Neurol. 2020;77(6):710\u20135. https:\/\/doi.org\/10.1001\/jamaneurol.2020.0187.","journal-title":"JAMA Neurol"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"107499","DOI":"10.1016\/j.clineuro.2022.107499","volume":"223","author":"T Tang","year":"2022","unstructured":"Tang T, Zhang R, Pan X. Meta-analysis of the risk of dementia in elderly patients with late-onset epilepsy. Clin Neurol Neurosurg. 2022;223:107499. https:\/\/doi.org\/10.1016\/j.clineuro.2022.107499.","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"1404_CR15","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s40520-022-02118-8","volume":"34","author":"L Huang","year":"2022","unstructured":"Huang L, Fu C, Li J, Peng S. Late-onset epilepsy and the risk of dementia: a systematic review and meta-analysis. Aging Clin Exp Res. 2022;34(8):1771\u20139. https:\/\/doi.org\/10.1007\/s40520-022-02118-8.","journal-title":"Aging Clin Exp Res"},{"key":"1404_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jocn.2021.01.030","volume":"86","author":"K Ophir","year":"2021","unstructured":"Ophir K, Ran B, Felix B, Amir G. Ten year cumulative incidence of dementia after late onset epilepsy of unknown etiology. J Clin Neurosci. 2021;86:247\u201351. https:\/\/doi.org\/10.1016\/j.jocn.2021.01.030.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"1404_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1684\/epd.2021.1360","volume":"24","author":"E Cvetkovska","year":"2022","unstructured":"Cvetkovska E, Babunovska M, Boskovski B, Kuzmanovski I, Tanovska N, Trencevska GK. Prevalence of various risk factors associated with new-onset epilepsy after the age of 50: a retrospective population-based study. Epileptic Disord. 2022;24(1):95\u2013101. https:\/\/doi.org\/10.1684\/epd.2021.1360.","journal-title":"Epileptic Disord"},{"issue":"1","key":"1404_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/brain\/awab268","volume":"145","author":"S Gourmaud","year":"2022","unstructured":"Gourmaud S, Stewart DA, Irwin DJ, et al. The role of mTORC1 activation in seizure-induced exacerbation of alzheimer\u2019s disease. Brain. 2022;145(1):324\u201339. https:\/\/doi.org\/10.1093\/brain\/awab268.","journal-title":"Brain"},{"key":"1404_CR19","doi-asserted-by":"publisher","first-page":"102591","DOI":"10.1016\/j.pneurobio.2024.102591","volume":"235","author":"A Del Pozo","year":"2024","unstructured":"Del Pozo A, Knox KM, Lehmann LM, et al. Chronic evoked seizures in young pre-symptomatic APP\/PS1 mice induce serotonin changes and accelerate onset of alzheimer\u2019s disease-related neuropathology. Prog Neurobiol. 2024;235:102591. https:\/\/doi.org\/10.1016\/j.pneurobio.2024.102591.","journal-title":"Prog Neurobiol"},{"key":"1404_CR20","doi-asserted-by":"publisher","first-page":"888784","DOI":"10.3389\/fnagi.2022.888784","volume":"14","author":"X Zheng","year":"2022","unstructured":"Zheng X, Zhang H, Lv Y, et al. Levetiracetam alleviates cognitive decline in alzheimer\u2019s disease animal model by ameliorating the dysfunction of the neuronal network. Front Aging Neurosci. 2022;14:888784. https:\/\/doi.org\/10.3389\/fnagi.2022.888784.","journal-title":"Front Aging Neurosci"},{"key":"1404_CR21","doi-asserted-by":"publisher","first-page":"637260","DOI":"10.3389\/fnagi.2021.637260","volume":"13","author":"X Wang","year":"2021","unstructured":"Wang X, Loi SM, Foster E, Chen Z, Velakoulis D, Kwan P. Predictors of new-onset epilepsy in people with younger-onset neurocognitive disorders. Front Aging Neurosci. 2021;13:637260. https:\/\/doi.org\/10.3389\/fnagi.2021.637260.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"1404_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/jamaneurol.2023.0339","volume":"80","author":"XY Tai","year":"2023","unstructured":"Tai XY, Torzillo E, Lyall DM, Manohar S, Husain M, Sen A. Association of dementia risk with focal epilepsy and modifiable cardiovascular risk factors. JAMA Neurol. 2023;80(5):445\u201354. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0339.","journal-title":"JAMA Neurol"},{"issue":"11","key":"1404_CR23","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2018.1935","volume":"75","author":"EL Johnson","year":"2018","unstructured":"Johnson EL, Krauss GL, Lee AK, et al. Association between midlife risk factors and late-onset epilepsy: results from the atherosclerosis risk in communities study. JAMA Neurol. 2018;75(11):1375\u201382. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1935.","journal-title":"JAMA Neurol"},{"issue":"3","key":"1404_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3233\/JAD-201462","volume":"81","author":"TJ Krivanek","year":"2021","unstructured":"Krivanek TJ, Gale SA, McFeeley BM, Nicastri CM, Daffner KR. Promoting successful cognitive aging: a ten-year update. J Alzheimers Dis. 2021;81(3):871\u2013920. https:\/\/doi.org\/10.3233\/JAD-201462.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1404_CR25","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3233\/JAD-221197","volume":"94","author":"G Hautecloque-Raysz","year":"2023","unstructured":"Hautecloque-Raysz G, Sellal F, Bousiges O, Phillipi N, Blanc F, Cretin B. Epileptic prodromal alzheimer\u2019s disease treated with antiseizure medications: medium-term outcome of seizures and cognition. J Alzheimers Dis. 2023;94(3):1057\u201374. https:\/\/doi.org\/10.3233\/JAD-221197.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"1404_CR26","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","volume":"78","author":"K Vossel","year":"2021","unstructured":"Vossel K, Ranasinghe KG, Beagle AJ, et al. Effect of levetiracetam on cognition in patients with alzheimer disease with and without epileptiform activity: a randomized clinical trial. JAMA Neurol. 2021;78(11):1345\u201354. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3310.","journal-title":"JAMA Neurol"},{"issue":"8","key":"1404_CR27","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.clinph.2021.03.050","volume":"132","author":"AA Horvath","year":"2021","unstructured":"Horvath AA, Papp A, Zsuffa J, et al. Subclinical epileptiform activity accelerates the progression of alzheimer\u2019s disease: a long-term EEG study. Clin Neurophysiol. 2021;132(8):1982\u20139. https:\/\/doi.org\/10.1016\/j.clinph.2021.03.050.","journal-title":"Clin Neurophysiol"},{"issue":"16","key":"1404_CR28","doi-asserted-by":"publisher","first-page":"e2259","DOI":"10.1212\/WNL.0000000000010612","volume":"95","author":"AD Lam","year":"2020","unstructured":"Lam AD, Sarkis RA, Pellerin KR, et al. Association of epileptiform abnormalities and seizures in alzheimer disease. Neurology. 2020;95(16):e2259\u201370. https:\/\/doi.org\/10.1212\/WNL.0000000000010612.","journal-title":"Neurology"},{"key":"1404_CR29","doi-asserted-by":"publisher","first-page":"101478","DOI":"10.1016\/j.arr.2021.101478","volume":"72","author":"B Zhao","year":"2021","unstructured":"Zhao B, Shen L, Ou Y, et al. Risk of seizures and subclinical epileptiform activity in patients with dementia: a systematic review and meta-analysis. Ageing Res Rev. 2021;72:101478. https:\/\/doi.org\/10.1016\/j.arr.2021.101478.","journal-title":"Ageing Res Rev"},{"issue":"5","key":"1404_CR30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.clinph.2020.02.015","volume":"131","author":"V Brunetti","year":"2020","unstructured":"Brunetti V, D\u2019Atri A, Della Marca G, et al. Subclinical epileptiform activity during sleep in alzheimer\u2019s disease and mild cognitive impairment. Clin Neurophysiol. 2020;131(5):1011\u20138. https:\/\/doi.org\/10.1016\/j.clinph.2020.02.015.","journal-title":"Clin Neurophysiol"},{"issue":"6","key":"1404_CR31","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.24794","volume":"80","author":"KA Vossel","year":"2016","unstructured":"Vossel KA, Ranasinghe KG, Beagle AJ, et al. Incidence and impact of subclinical epileptiform activity in alzheimer\u2019s disease. Ann Neurol. 2016;80(6):858\u201370. https:\/\/doi.org\/10.1002\/ana.24794.","journal-title":"Ann Neurol"},{"key":"1404_CR32","doi-asserted-by":"publisher","first-page":"106149","DOI":"10.1016\/j.nbd.2023.106149","volume":"183","author":"CS Musaeus","year":"2023","unstructured":"Musaeus CS, Frederiksen KS, Andersen BB, et al. Detection of subclinical epileptiform discharges in alzheimer\u2019s disease using long-term outpatient EEG monitoring. Neurobiol Dis. 2023;183:106149. https:\/\/doi.org\/10.1016\/j.nbd.2023.106149.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1404_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3233\/JAD-220567","volume":"90","author":"W Yeh","year":"2022","unstructured":"Yeh W, Hsu C, Li K, Chien C, Huang L, Yang Y. Association between subclinical epileptiform discharge and the severity of cognitive decline in alzheimer\u2019s disease: a longitudinal cohort study. J Alzheimers Dis. 2022;90(1):305\u201312. https:\/\/doi.org\/10.3233\/JAD-220567.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1404_CR34","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/brain\/awae126","volume":"147","author":"AJ Barbour","year":"2024","unstructured":"Barbour AJ, Gourmaud S, Lancaster E, et al. Seizures exacerbate excitatory: inhibitory imbalance in alzheimer\u2019s disease and 5XFAD mice. Brain. 2024;147(6):2169\u201384. https:\/\/doi.org\/10.1093\/brain\/awae126.","journal-title":"Brain"},{"issue":"12","key":"1404_CR35","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1111\/epi.17781","volume":"64","author":"AB Silva","year":"2023","unstructured":"Silva AB, Leonard MK, Oganian Y, et al. Interictal epileptiform discharges contribute to word-finding difficulty in epilepsy through multiple cognitive mechanisms. Epilepsia. 2023;64(12):3266\u201378. https:\/\/doi.org\/10.1111\/epi.17781.","journal-title":"Epilepsia"},{"issue":"9","key":"1404_CR36","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1111\/epi.17334","volume":"63","author":"L Camarillo-Rodriguez","year":"2022","unstructured":"Camarillo-Rodriguez L, Leenen I, Waldman Z, et al. Temporal lobe interictal spikes disrupt encoding and retrieval of verbal memory: a subregion analysis. Epilepsia. 2022;63(9):2325\u201337. https:\/\/doi.org\/10.1111\/epi.17334.","journal-title":"Epilepsia"},{"issue":"8","key":"1404_CR37","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/brain\/awae119","volume":"147","author":"A Wodeyar","year":"2024","unstructured":"Wodeyar A, Chinappen D, Mylonas D, et al. Thalamic epileptic spikes disrupt sleep spindles in patients with epileptic encephalopathy. Brain. 2024;147(8):2803\u201316. https:\/\/doi.org\/10.1093\/brain\/awae119.","journal-title":"Brain"},{"issue":"4","key":"1404_CR38","doi-asserted-by":"publisher","first-page":"e13622","DOI":"10.1111\/jsr.13622","volume":"31","author":"L Nobili","year":"2022","unstructured":"Nobili L, Frauscher B, Eriksson S, et al. Sleep and epilepsy: a snapshot of knowledge and future research lines. J Sleep Res. 2022;31(4):e13622. https:\/\/doi.org\/10.1111\/jsr.13622.","journal-title":"J Sleep Res"},{"issue":"10","key":"1404_CR39","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1111\/epi.17707","volume":"64","author":"RA Sarkis","year":"2023","unstructured":"Sarkis RA, Lam AD, Pavlova M, et al. Epilepsy and sleep characteristics are associated with diminished 24-h memory retention in older adults with epilepsy. Epilepsia. 2023;64(10):2771\u201380. https:\/\/doi.org\/10.1111\/epi.17707.","journal-title":"Epilepsia"},{"issue":"32","key":"1404_CR40","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1523\/JNEUROSCI.0503-19.2019","volume":"39","author":"JR Winer","year":"2019","unstructured":"Winer JR, Mander BA, Helfrich RF, et al. Sleep as a potential biomarker of tau and \u03b2-amyloid burden in the human brain. J Neurosci. 2019;39(32):6315\u201324. https:\/\/doi.org\/10.1523\/JNEUROSCI.0503-19.2019.","journal-title":"J Neurosci"},{"issue":"1","key":"1404_CR41","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/epi.17462","volume":"64","author":"CP Lisgaras","year":"2023","unstructured":"Lisgaras CP, Scharfman HE. High-frequency oscillations (250\u2013500 hz) in animal models of alzheimer\u2019s disease and two animal models of epilepsy. Epilepsia. 2023;64(1):231\u201346. https:\/\/doi.org\/10.1111\/epi.17462.","journal-title":"Epilepsia"},{"issue":"11","key":"1404_CR42","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","volume":"29","author":"R Minkeviciene","year":"2009","unstructured":"Minkeviciene R, Rheims S, Dobszay MB, et al. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci. 2009;29(11):3453\u201362. https:\/\/doi.org\/10.1523\/JNEUROSCI.5215-08.2009.","journal-title":"J Neurosci"},{"issue":"1","key":"1404_CR43","doi-asserted-by":"publisher","first-page":"13592","DOI":"10.1038\/s41598-019-50018-1","volume":"9","author":"R Ciccone","year":"2019","unstructured":"Ciccone R, Franco C, Piccialli I, et al. Amyloid \u03b2-induced upregulation of na(v)1.6 underlies neuronal hyperactivity in Tg2576 alzheimer\u2019s disease mouse model. Sci Rep. 2019;9(1):13592\u20131. https:\/\/doi.org\/10.1038\/s41598-019-50018-1.","journal-title":"Sci Rep"},{"issue":"1","key":"1404_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3233\/JAD-160041","volume":"53","author":"KN Hascup","year":"2016","unstructured":"Hascup KN, Hascup ER. Soluble amyloid-\u03b242 stimulates glutamate release through activation of the \u03b17 nicotinic acetylcholine receptor. J Alzheimers Dis. 2016;53(1):337\u201347. https:\/\/doi.org\/10.3233\/JAD-160041.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1404_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13024-020-00393-5","volume":"15","author":"ECB Johnson","year":"2020","unstructured":"Johnson ECB, Ho K, Yu G, et al. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of app knock-in mice and are modulated by familial alzheimer\u2019s disease mutations but not by inhibition of BACE1. Mol Neurodegener. 2020;15(1):53\u20135. https:\/\/doi.org\/10.1186\/s13024-020-00393-5.","journal-title":"Mol Neurodegener"},{"issue":"12","key":"1404_CR46","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/ejn.13983","volume":"47","author":"T Gschwind","year":"2018","unstructured":"Gschwind T, Lafourcade C, Gfeller T, et al. Contribution of early alzheimer\u2019s disease-related pathophysiology to the development of acquired epilepsy. Eur J Neurosci. 2018;47(12):1534\u201362. https:\/\/doi.org\/10.1111\/ejn.13983.","journal-title":"Eur J Neurosci"},{"issue":"4","key":"1404_CR47","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/epi.17186","volume":"63","author":"G Canet","year":"2022","unstructured":"Canet G, Zub E, Zussy C, et al. Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways. Epilepsia. 2022;63(4):919\u201335. https:\/\/doi.org\/10.1111\/epi.17186.","journal-title":"Epilepsia"},{"issue":"1","key":"1404_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/brain\/awz381","volume":"143","author":"S Gourmaud","year":"2020","unstructured":"Gourmaud S, Shou H, Irwin DJ, et al. Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy. Brain. 2020;143(1):191\u2013209. https:\/\/doi.org\/10.1093\/brain\/awz381.","journal-title":"Brain"},{"key":"1404_CR49","doi-asserted-by":"publisher","first-page":"113766","DOI":"10.1016\/j.expneurol.2021.113766","volume":"343","author":"RA Cloyd","year":"2021","unstructured":"Cloyd RA, Koren J, Abisambra JF, Smith BN. Effects of altered tau expression on dentate granule cell excitability in mice. Exp Neurol. 2021;343:113766. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113766.","journal-title":"Exp Neurol"},{"key":"1404_CR50","doi-asserted-by":"publisher","first-page":"633725","DOI":"10.3389\/fcell.2020.633725","volume":"8","author":"Y Gao","year":"2021","unstructured":"Gao Y, Zheng J, Jiang T, et al. Targeted reducing of tauopathy alleviates epileptic seizures and spatial memory impairment in an optogenetically inducible mouse model of epilepsy. Front Cell Dev Biol. 2021;8:633725. https:\/\/doi.org\/10.3389\/fcell.2020.633725.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"1404_CR51","doi-asserted-by":"publisher","first-page":"109855","DOI":"10.1016\/j.celrep.2021.109855","volume":"37","author":"C Chang","year":"2021","unstructured":"Chang C, Evans MD, Yu X, Yu G, Mucke L. Tau reduction affects excitatory and inhibitory neurons differently, reduces excitation\/inhibition ratios, and counteracts network hypersynchrony. Cell Rep. 2021;37(3):109855. https:\/\/doi.org\/10.1016\/j.celrep.2021.109855.","journal-title":"Cell Rep"},{"issue":"9","key":"1404_CR52","doi-asserted-by":"publisher","first-page":"e209920","DOI":"10.1212\/WNL.0000000000209920","volume":"103","author":"AD Lam","year":"2024","unstructured":"Lam AD, Thibault EG, Mayblyum DV, et al. Association of seizure foci and location of tau and amyloid deposition and brain atrophy in patients with alzheimer disease and seizures. Neurology. 2024;103(9):e209920. https:\/\/doi.org\/10.1212\/WNL.0000000000209920.","journal-title":"Neurology"},{"issue":"7","key":"1404_CR53","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/RLU.0000000000003662","volume":"46","author":"H Yoon","year":"2021","unstructured":"Yoon H, Kim BS, Jeong JH, Kim GH, Park HK, Chun MY. Asymmetric amyloid deposition as an early sign of progression in mild cognitive impairment due to alzheimer disease. Clin Nucl Med. 2021;46(7):527\u201331. https:\/\/doi.org\/10.1097\/RLU.0000000000003662.","journal-title":"Clin Nucl Med"},{"key":"1404_CR54","doi-asserted-by":"publisher","first-page":"103416","DOI":"10.1016\/j.nicl.2023.103416","volume":"38","author":"J Lu","year":"2023","unstructured":"Lu J, Zhang Z, Wu P, et al. The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in alzheimer\u2019s disease. Neuroimage Clin. 2023;38:103416. https:\/\/doi.org\/10.1016\/j.nicl.2023.103416.","journal-title":"Neuroimage Clin"},{"issue":"6","key":"1404_CR55","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/jamaneurol.2022.0676","volume":"79","author":"CB Young","year":"2022","unstructured":"Young CB, Winer JR, Younes K, et al. Divergent cortical tau positron emission tomography patterns among patients with preclinical alzheimer disease. JAMA Neurol. 2022;79(6):592\u2013603. https:\/\/doi.org\/10.1001\/jamaneurol.2022.0676.","journal-title":"JAMA Neurol"},{"issue":"5","key":"1404_CR56","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel JW, Young AL, Oxtoby NP, et al. Four distinct trajectories of tau deposition identified in alzheimer\u2019s disease. Nat Med. 2021;27(5):871\u201381. https:\/\/doi.org\/10.1038\/s41591-021-01309-6.","journal-title":"Nat Med"},{"key":"1404_CR57","doi-asserted-by":"publisher","first-page":"100048","DOI":"10.1016\/j.nbas.2022.100048","volume":"2","author":"PL Kjeldsen","year":"2022","unstructured":"Kjeldsen PL, Parbo P, Hansen KV, et al. Asymmetric amyloid deposition in preclinical alzheimer\u2019s disease: a PET study. Aging Brain. 2022;2:100048. https:\/\/doi.org\/10.1016\/j.nbas.2022.100048.","journal-title":"Aging Brain"},{"key":"1404_CR58","doi-asserted-by":"publisher","first-page":"105274","DOI":"10.1016\/j.nbd.2021.105274","volume":"152","author":"D Alcantara-Gonzalez","year":"2021","unstructured":"Alcantara-Gonzalez D, Chartampila E, Criscuolo C, Scharfman HE. Early changes in synaptic and intrinsic properties of dentate gyrus granule cells in a mouse model of alzheimer\u2019s disease neuropathology and atypical effects of the cholinergic antagonist atropine. Neurobiol Dis. 2021;152:105274. https:\/\/doi.org\/10.1016\/j.nbd.2021.105274.","journal-title":"Neurobiol Dis"},{"key":"1404_CR59","doi-asserted-by":"publisher","first-page":"106294","DOI":"10.1016\/j.nbd.2023.106294","volume":"187","author":"CP Lisgaras","year":"2023","unstructured":"Lisgaras CP, Scharfman HE. Interictal spikes in alzheimer\u2019s disease: preclinical evidence for dominance of the dentate gyrus and cholinergic control by the medial septum. Neurobiol Dis. 2023;187:106294. https:\/\/doi.org\/10.1016\/j.nbd.2023.106294.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1404_CR60","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41582-024-00932-4","volume":"20","author":"A Kamondi","year":"2024","unstructured":"Kamondi A, Grigg-Damberger M, L\u00f6scher W, Tanila H, Horvath AA. Epilepsy and epileptiform activity in late-onset alzheimer disease: clinical and pathophysiological advances, gaps and conundrums. Nat Rev Neurol. 2024;20(3):162\u201382. https:\/\/doi.org\/10.1038\/s41582-024-00932-4.","journal-title":"Nat Rev Neurol"},{"key":"1404_CR61","doi-asserted-by":"publisher","first-page":"1277613","DOI":"10.3389\/fneur.2024.1277613","volume":"15","author":"M Vicente","year":"2024","unstructured":"Vicente M, Addo-Osafo K, Vossel K. Latest advances in mechanisms of epileptic activity in alzheimer\u2019s disease and dementia with lewy bodies. Front Neurol. 2024;15:1277613. https:\/\/doi.org\/10.3389\/fneur.2024.1277613.","journal-title":"Front Neurol"},{"issue":"21","key":"1404_CR62","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.3390\/ijms222111677","volume":"22","author":"GA Czapski","year":"2021","unstructured":"Czapski GA, Strosznajder JB. Glutamate and GABA in microglia-neuron cross-talk in alzheimer\u2019s disease. Int J Mol Sci. 2021;22(21):11677. https:\/\/doi.org\/10.3390\/ijms222111677.","journal-title":"Int J Mol Sci"},{"issue":"6453","key":"1404_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, et al. A vicious cycle of \u03b2 amyloid-dependent neuronal hyperactivation. Science. 2019;365(6453):559\u201365. https:\/\/doi.org\/10.1126\/science.aay0198.","journal-title":"Science"},{"issue":"2\u20133","key":"1404_CR64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00429-010-0242-4","volume":"214","author":"H Takahashi","year":"2010","unstructured":"Takahashi H, Brasnjevic I, Rutten BPF, et al. Hippocampal interneuron loss in an APP\/PS1 double mutant mouse and in alzheimer\u2019s disease. Brain Struct Funct. 2010;214(2\u20133):145\u201360. https:\/\/doi.org\/10.1007\/s00429-010-0242-4.","journal-title":"Brain Struct Funct"},{"issue":"1","key":"1404_CR65","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s42003-022-04268-x","volume":"5","author":"M Algamal","year":"2022","unstructured":"Algamal M, Russ AN, Miller MR, et al. Reduced excitatory neuron activity and interneuron-type-specific deficits in a mouse model of alzheimer\u2019s disease. Commun Biol. 2022;5(1):1323\u2013x. https:\/\/doi.org\/10.1038\/s42003-022-04268-x.","journal-title":"Commun Biol"},{"issue":"26","key":"1404_CR66","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1523\/JNEUROSCI.0425-20.2020","volume":"40","author":"A Caccavano","year":"2020","unstructured":"Caccavano A, Bozzelli PL, Forcelli PA, et al. Inhibitory parvalbumin basket cell activity is selectively reduced during hippocampal sharp wave ripples in a mouse model of familial alzheimer\u2019s disease. J Neurosci. 2020;40(26):5116\u201336. https:\/\/doi.org\/10.1523\/JNEUROSCI.0425-20.2020.","journal-title":"J Neurosci"},{"key":"1404_CR67","doi-asserted-by":"publisher","first-page":"175909142092535","DOI":"10.1177\/1759091420925356","volume":"12","author":"NK Giesers","year":"2020","unstructured":"Giesers NK, Wirths O. Loss of hippocampal calretinin and parvalbumin interneurons in the 5XFAD mouse model of alzheimer\u2019s disease. ASN Neuro. 2020;12:1759091420925356. https:\/\/doi.org\/10.1177\/1759091420925356.","journal-title":"ASN Neuro"},{"issue":"5","key":"1404_CR68","doi-asserted-by":"publisher","first-page":"e0233700","DOI":"10.1371\/journal.pone.0233700","volume":"15","author":"KE Sos","year":"2020","unstructured":"Sos KE, Mayer MI, Tak\u00e1cs VT, et al. Amyloid \u03b2 induces interneuron-specific changes in the hippocampus of APPNL-F mice. PLoS ONE. 2020;15(5):e0233700. https:\/\/doi.org\/10.1371\/journal.pone.0233700.","journal-title":"PLoS ONE"},{"issue":"5","key":"1404_CR69","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/jnc.14325","volume":"145","author":"A Kwakowsky","year":"2018","unstructured":"Kwakowsky A, Calvo-Flores Guzm\u00e1n B, Pandya M, Turner C, Waldvogel HJ, Faull RL. GABA(A) receptor subunit expression changes in the human alzheimer\u2019s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus. J Neurochem. 2018;145(5):374\u201392. https:\/\/doi.org\/10.1111\/jnc.14325.","journal-title":"J Neurochem"},{"issue":"17","key":"1404_CR70","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1523\/JNEUROSCI.6495-11.2012","volume":"32","author":"MD Eyre","year":"2012","unstructured":"Eyre MD, Renzi M, Farrant M, Nusser Z. Setting the time course of inhibitory synaptic currents by mixing multiple GABA(A) receptor \u03b1 subunit isoforms. J Neurosci. 2012;32(17):5853\u201367. https:\/\/doi.org\/10.1523\/JNEUROSCI.6495-11.2012.","journal-title":"J Neurosci"},{"issue":"10","key":"1404_CR71","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/2661","volume":"4","author":"AR Brooks-Kayal","year":"1998","unstructured":"Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat Med. 1998;4(10):1166\u201372. https:\/\/doi.org\/10.1038\/2661.","journal-title":"Nat Med"},{"issue":"3","key":"1404_CR72","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1124\/jpet.104.068478","volume":"310","author":"RE Blair","year":"2004","unstructured":"Blair RE, Sombati S, Lawrence DC, McCay BD, DeLorenzo RJ. Epileptogenesis causes acute and chronic increases in GABAA receptor endocytosis that contributes to the induction and maintenance of seizures in the hippocampal culture model of acquired epilepsy. J Pharmacol Exp Ther. 2004;310(3):871\u201380. https:\/\/doi.org\/10.1124\/jpet.104.068478.","journal-title":"J Pharmacol Exp Ther"},{"issue":"22","key":"1404_CR73","doi-asserted-by":"publisher","first-page":"8465","DOI":"10.1073\/pnas.0602979103","volume":"103","author":"E Palma","year":"2006","unstructured":"Palma E, Amici M, Sobrero F, et al. Anomalous levels of cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory. Proc Natl Acad Sci U S A. 2006;103(22):8465\u20138. https:\/\/doi.org\/10.1073\/pnas.0602979103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1404_CR74","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.3390\/molecules27082440","volume":"27","author":"P Lam","year":"2022","unstructured":"Lam P, Vinnakota C, Guzm\u00e1n BC, et al. Beta-amyloid (a\u03b2(1\u201342)) increases the expression of NKCC1 in the mouse hippocampus. Molecules. 2022;27(8):2440. https:\/\/doi.org\/10.3390\/molecules27082440.","journal-title":"Molecules"},{"issue":"12","key":"1404_CR75","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1093\/brain\/awad250","volume":"146","author":"I Keramidis","year":"2023","unstructured":"Keramidis I, McAllister BB, Bourbonnais J, et al. Restoring neuronal chloride extrusion reverses cognitive decline linked to alzheimer\u2019s disease mutations. Brain. 2023;146(12):4903\u201315. https:\/\/doi.org\/10.1093\/brain\/awad250.","journal-title":"Brain"},{"key":"1404_CR76","doi-asserted-by":"publisher","first-page":"104719","DOI":"10.1016\/j.nbd.2019.104719","volume":"136","author":"M Beckman","year":"2020","unstructured":"Beckman M, Knox K, Koneval Z, Smith C, Jayadev S, Barker-Haliski M. Loss of presenilin 2 age-dependently alters susceptibility to acute seizures and kindling acquisition. Neurobiol Dis. 2020;136:104719. https:\/\/doi.org\/10.1016\/j.nbd.2019.104719.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"1404_CR77","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1038\/s41467-021-22742-8","volume":"12","author":"JC Lauterborn","year":"2021","unstructured":"Lauterborn JC, Scaduto P, Cox CD, et al. Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with alzheimer\u2019s disease. Nat Commun. 2021;12(1):2603\u20138. https:\/\/doi.org\/10.1038\/s41467-021-22742-8.","journal-title":"Nat Commun"},{"issue":"198","key":"1404_CR78","doi-asserted-by":"publisher","first-page":"20220607","DOI":"10.1098\/rsif.2022.0607","volume":"20","author":"CG Alexandersen","year":"2023","unstructured":"Alexandersen CG, de Haan W, Bick C, Goriely A. A multi-scale model explains oscillatory slowing and neuronal hyperactivity in alzheimer\u2019s disease. J R Soc Interface. 2023;20(198):20220607. https:\/\/doi.org\/10.1098\/rsif.2022.0607.","journal-title":"J R Soc Interface"},{"key":"1404_CR79","doi-asserted-by":"publisher","unstructured":"Ranasinghe KG, Verma P, Cai C, et al. Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in alzheimer\u2019s disease. Elife. 2022;11. https:\/\/doi.org\/10.7554\/eLife.77850.","DOI":"10.7554\/eLife.77850"},{"issue":"1","key":"1404_CR80","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13195-022-01041-4","volume":"14","author":"AM van Nifterick","year":"2022","unstructured":"van Nifterick AM, Gouw AA, van Kesteren RE, Scheltens P, Stam CJ, de Haan W. A multiscale brain network model links alzheimer\u2019s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing. Alzheimers Res Ther. 2022;14(1):101\u20134. https:\/\/doi.org\/10.1186\/s13195-022-01041-4.","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"1404_CR81","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1038\/s41593-024-01763-8","volume":"27","author":"J Gallego-Rudolf","year":"2024","unstructured":"Gallego-Rudolf J, Wiesman AI, Pichet Binette A, Villeneuve S, Baillet S, PREVENT-AD Research Group. Synergistic association of a\u03b2 and tau pathology with cortical neurophysiology and cognitive decline in asymptomatic older adults. Nat Neurosci. 2024;27(11):2130\u20137. https:\/\/doi.org\/10.1038\/s41593-024-01763-8.","journal-title":"Nat Neurosci"},{"issue":"1","key":"1404_CR82","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel JW, Iturria-Medina Y, Strandberg OT, et al. Spread of pathological tau proteins through communicating neurons in human alzheimer\u2019s disease. Nat Commun. 2020;11(1):2612\u20132. https:\/\/doi.org\/10.1038\/s41467-020-15701-2.","journal-title":"Nat Commun"},{"issue":"10","key":"1404_CR83","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41583-023-00731-8","volume":"24","author":"JW Vogel","year":"2023","unstructured":"Vogel JW, Corriveau-Lecavalier N, Franzmeier N, et al. Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight. Nat Rev Neurosci. 2023;24(10):620\u201339. https:\/\/doi.org\/10.1038\/s41583-023-00731-8.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"1404_CR84","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1007\/s00259-020-05183-1","volume":"48","author":"J Seemiller","year":"2021","unstructured":"Seemiller J, Bischof GN, Hoenig MC, et al. Indication of retrograde tau spreading along braak stages and functional connectivity pathways. Eur J Nucl Med Mol Imaging. 2021;48(7):2272\u201382. https:\/\/doi.org\/10.1007\/s00259-020-05183-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"24","key":"1404_CR85","doi-asserted-by":"publisher","first-page":"eabg6677","DOI":"10.1126\/sciadv.abg6677","volume":"7","author":"EJ Cornblath","year":"2021","unstructured":"Cornblath EJ, Li HL, Changolkar L, et al. Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor. Sci Adv. 2021;7(24):eabg6677. https:\/\/doi.org\/10.1126\/sciadv.abg6677. Print 2021 Jun.","journal-title":"Sci Adv"},{"issue":"1","key":"1404_CR86","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41467-019-14159-1","volume":"11","author":"N Franzmeier","year":"2020","unstructured":"Franzmeier N, Neitzel J, Rubinski A, et al. Functional brain architecture is associated with the rate of tau accumulation in alzheimer\u2019s disease. Nat Commun. 2020;11(1):347\u20131. https:\/\/doi.org\/10.1038\/s41467-019-14159-1.","journal-title":"Nat Commun"},{"issue":"5","key":"1404_CR87","doi-asserted-by":"publisher","first-page":"CD011922","DOI":"10.1002\/14651858.CD011922.pub4","volume":"5","author":"J Liu","year":"2021","unstructured":"Liu J, Wang L. Treatment of epilepsy for people with alzheimer\u2019s disease. Cochrane Database Syst Rev. 2021;5(5):CD011922. https:\/\/doi.org\/10.1002\/14651858.CD011922.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1404_CR88","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","volume":"17","author":"E Cumbo","year":"2010","unstructured":"Cumbo E, Ligori LD. Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and alzheimer\u2019s disease. Epilepsy Behav. 2010;17(4):461\u20136. https:\/\/doi.org\/10.1016\/j.yebeh.2010.01.015.","journal-title":"Epilepsy Behav"},{"issue":"10","key":"1404_CR89","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1111\/epi.17355","volume":"63","author":"M Vande Vyver","year":"2022","unstructured":"Vande Vyver M, Barker-Haliski M, Aourz N, et al. Higher susceptibility to 6 hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of alzheimer\u2019s disease. Epilepsia. 2022;63(10):2703\u201315. https:\/\/doi.org\/10.1111\/epi.17355.","journal-title":"Epilepsia"},{"issue":"2","key":"1404_CR90","doi-asserted-by":"publisher","first-page":"e12385","DOI":"10.1002\/trc2.12385","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement (N Y). 2023;9(2):e12385. https:\/\/doi.org\/10.1002\/trc2.12385.","journal-title":"Alzheimers Dement (N Y)"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01404-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01404-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01404-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:52:41Z","timestamp":1739001161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01404-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01404-y","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,8]]},"assertion":[{"value":"27 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"18"}}